Komen Debuts New Websites on Breast Cancer

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 12
Volume 6
Issue 12

DALLAS-The Susan G. Komen Breast Cancer Foundation, known for raising awareness and community support for breast cancer research and programs through its Race for the Cure, has unveiled three new websites that form a comprehensive online source of breast health and breast cancer information.

DALLAS—The Susan G. Komen Breast Cancer Foundation, known for raising awareness and community support for breast cancer research and programs through its Race for the Cure, has unveiled three new websites that form a comprehensive online source of breast health and breast cancer information.

“We’ve developed a sound source of trusted information that can be tapped into anytime, day or night,” said Nancy Brinker, founding chairman of the Komen Foundation. “And we’ve gone a step further by providing people the ability to share their personal experiences on our websites, creating a sense of empowerment and community spirit online.”

Internet users can access the websites by using one of three Internet addresses: (1) www.breastcancerinfo.com, (2) www.raceforthecure.com, and (3) www.komen.org. Once logged on to any of the three sites, a toolbar allows easy access to the information on all three.

The site includes more than 100 pages of breast health information, areas designed for breast cancer survivors and their families, information on the Race for the Cure, and a calendar of breast cancer-related events and programs. Researchers can use the site to access applications for Komen Foundation grants.

A series of “Talk Back” sections encourage visitor participation and involvement by allowing users to share their first-hand experience with breast cancer.

Funds raised through the Lee National Denim Day in 1996 helped underwrite the website. The Lee Company invites corporations to participate by allowing their employees to wear denim to work on that day in exchange for a $5 contribution to the Komen Foundation.

Recent Videos
Updated results from the 1b/2 ELEVATE study elucidate synergizing effects observed with elacestrant plus targeted therapies in ER+/HER2– breast cancer.
Patients with ESR1+, ER+/HER2– breast cancer resistant to chemotherapy may benefit from combination therapy with elacestrant.
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.